[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inmed Pharmaceuticals Inc (INM)

Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,004
  • Shares Outstanding, K 3,314
  • Annual Sales, $ 4,940 K
  • Annual Income, $ -8,160 K
  • EBIT $ -8 M
  • EBITDA $ -7 M
  • 60-Month Beta 0.98
  • Price/Sales 1.03
  • Price/Cash Flow N/A
  • Price/Book 0.74

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6210 +149.60%
on 05/12/26
1.9900 -22.11%
on 05/22/26
+0.9290 (+149.60%)
since 05/11/26
3-Month
0.5750 +169.57%
on 03/31/26
1.9900 -22.11%
on 05/22/26
+0.7500 (+93.75%)
since 03/11/26
52-Week
0.5750 +169.57%
on 03/31/26
5.5000 -71.82%
on 06/24/25
-1.0000 (-39.22%)
since 06/11/25

Most Recent Stories

More News
InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements

Vancouver, British Columbia--(Newsfile Corp. - June 4, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), today announce that it had received written notice from the Listing...

INM : 1.5500 (+2.65%)
Are RAMP, INM, D, NEE Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

D : 67.11 (+0.51%)
RAMP : 37.60 (-0.19%)
INM : 1.5500 (+2.65%)
NEE : 85.09 (-0.04%)
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RAMP, NEE, D, and INM

NEW YORK , May 28, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

D : 67.11 (+0.51%)
RAMP : 37.60 (-0.19%)
INM : 1.5500 (+2.65%)
NEE : 85.09 (-0.04%)
INM Stock Alert: What to Know as InMed, Mentari Announce Merger

InMed stock rallied yesterday on a merger announcement with Mentari Therapeutics. Here’s why the transaction is concerning for INM investors.

INM : 1.5500 (+2.65%)
INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior...

INM : 1.5500 (+2.65%)
InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies

Mentari's parallel lead programs target validated, complementary pathways with potential to address the two-thirds of patients who have a suboptimal response to anti-CGRP therapies

INM : 1.5500 (+2.65%)
InMed Pharmaceuticals Amends Preferred Investment Options

Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 1.5500 (+2.65%)
InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update

Vancouver, British Columbia--(Newsfile Corp. - May 6, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 1.5500 (+2.65%)
InMed Pharmaceuticals Amends Preferred Investment Options

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 1.5500 (+2.65%)
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

Vancouver, British Columbia--(Newsfile Corp. - March 27, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company developing a pipeline of disease-modifying...

INM : 1.5500 (+2.65%)

Business Summary

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.

See More

Key Turning Points

3rd Resistance Point 1.5983
2nd Resistance Point 1.5567
1st Resistance Point 1.5333
Last Price 1.5500
1st Support Level 1.4683
2nd Support Level 1.4267
3rd Support Level 1.4033

See More

52-Week High 5.5000
Fibonacci 61.8% 3.6186
Fibonacci 50% 3.0375
Fibonacci 38.2% 2.4564
Last Price 1.5500
52-Week Low 0.5750

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.